DNA Methylation and Colorectal Cancer

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Colorectal cancer (CRC) is a leading cause of cancer-related mortality globally and in the US.
• CRC development is characterized by genetic and epigenetic alterations, with DNA methylation playing a crucial role.
• Aberrant DNA methylation patterns are implicated in various stages of CRC, including promoter silencing and oncogene hypomethylation.

Purpose of the Study:

• To review and define the methylation signatures associated with colorectal cancer.
• To explore the potential of DNA methylation as a diagnostic and prognostic marker in CRC.
• To highlight the role of CpG Islands Methylator Phenotype (CIMP) in CRC pathogenesis.

Main Methods:

• Literature review focusing on DNA methylation studies in colorectal cancer.
• Analysis of epigenetic alterations, including promoter methylation and hypomethylation.
• Examination of the relationship between methylation profiles and pathological diagnosis.

Main Results:

• DNA methylation changes are integral to CRC development and gene expression.
• Methylation patterns can serve as valuable tools for the early detection of colonic lesions.
• CpG Islands Methylator Phenotype (CIMP) represents a significant mechanism in CRC.

Conclusions:

• DNA methylation signatures are critical for understanding CRC.
• Integrating DNA methylation analysis with pathological diagnosis can enhance the prediction of tumor evolution and prognosis.
• Epigenetic markers hold promise for improved CRC management.